UChicago Breast and Lymphedema Symposium 2019
Abemaciclib + Anastrozole Are Effective With Manageable Toxicities in HR+/HER2- Early Breast Cancer / Neoadjuvant Pertuzumab and Trastuzumab in HER2+ Breast Cancer and Long Term Efficacy
By
UChicago Breast and Lymphedema Symposium 2019
FEATURING
Rita Nanda
By
UChicago Breast and Lymphedema Symposium 2019
FEATURING
Rita Nanda
Login to view comments.
Click here to Login
Breast Oncology